CFO of ONYX Pharmaceuticals Inc. (ONXX, Financial) Matthew K Fust sells 1,812 shares of ONXX on 01/06/2011 at an average price of $37.28 a share.
Onyx Pharmaceuticals Inc. has a market cap of $2.26 billion; its shares were traded at around $35.96 with a P/E ratio of 65.3 and P/S ratio of 9.
ONXX is in the portfolios of Edward Owens of Vanguard Health Care Fund, Stanley Druckenmiller of Duquesne Capital Management, LLC, Columbia Wanger of Columbia Wanger Asset Management, Louis Moore Bacon of Moore Capital Management, LP, George Soros of Soros Fund Management LLC.
Onyx Pharmaceuticals Inc. has a market cap of $2.26 billion; its shares were traded at around $35.96 with a P/E ratio of 65.3 and P/S ratio of 9.
ONXX is in the portfolios of Edward Owens of Vanguard Health Care Fund, Stanley Druckenmiller of Duquesne Capital Management, LLC, Columbia Wanger of Columbia Wanger Asset Management, Louis Moore Bacon of Moore Capital Management, LP, George Soros of Soros Fund Management LLC.
CEO Recent Trades:
- Sell: President & CEO N Anthony Coles sold 13,669 shares of ONXX stock on 12/07/2010 at the average price of 32. N Anthony Coles owns at least 49,633 shares after this. The price of the stock has increased by 12.38% since.
- Sell: President & CEO N Anthony Coles sold 20,000 shares of ONXX stock on 08/19/2010 at the average price of 26.4. N Anthony Coles owns at least 63,302 shares after this. The price of the stock has increased by 36.21% since.
Directors and Officers Recent Trades:
- Sell: VP, Corp. Communication/I.R. Julianna R Wood sold 2,098 shares of ONXX stock on 12/14/2010 at the average price of 35. Julianna R Wood owns at least 8,653 shares after this. The price of the stock has increased by 2.74% since.
- Sell: EVP & COO Laura Brege sold 25,000 shares of ONXX stock on 11/08/2010 at the average price of 30. Laura Brege owns at least 18,514 shares after this. The price of the stock has increased by 19.87% since.